540222:BOM
Laurus Labs Ltd
₹2,062.40
arrow_upward
+0.17%(+3.40) 1D
Okt 19, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 540222...
Buksan
₹2,064.00
Mataas
₹2,087.00
Mababa
₹2,055.00
Mkt. cap
1.11T
Avg. na dami
88.05K
Dami
29.90K
Dividend
0.10%
Bawat tatlong buwang dividend
₹0.50
Petsa ng ex-dividend
May 8, 2026
P/E ratio
101.97
Mataas nang 52-wk
₹2,087.00
Mababa nang 52-wk
₹901.85
EPS
₹20.23
Mga natitirang share
106.44M
Bilang ng mga empleyado
7K
Buksan
₹2,064.00
Mataas
₹2,087.00
Mababa
₹2,055.00
Mkt. cap
1.11T
Avg. na dami
88.05K
Dami
29.90K
Dividend
0.10%
Bawat tatlong buwang dividend
₹0.50
Petsa ng ex-dividend
May 8, 2026
P/E ratio
101.97
Mataas nang 52-wk
₹2,087.00
Mababa nang 52-wk
₹901.85
EPS
₹20.23
Mga natitirang share
106.44M
Bilang ng mga empleyado
7K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Business Standard
·
4 oras ang nakalipas
Laurus Labs zooms 128% from March low; hits new high in weak market
Univest
·
6 oras ang nakalipas
Top Hyderabad-based Stocks 2026: Divi's Labs, Laurus Labs, NMDC
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Tungkol sa Laurus Labs Ltd